Adzine 200 Injection
Marketer
Admac Pharma Ltd
Salt Composition
Dacarbazine (200mg)
Overview Adzine 200 Injection
Lymphoma and malignant melanoma (a skin cancer) are treated with Adzine 200 Injection. Other uses may be determined by your physician. Administered intravenously by a medical professional, ideally at the same time daily, the dosage and frequency are prescribed by your doctor based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can lead to severe consequences. Therapeutic effects may take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include nausea, vomiting, low white blood cell count, and injection site discomfort; report persistent or worsening symptoms. Strategies to mitigate these effects exist. Serious adverse reactions are possible; monitor for unusual bleeding/bruising, fatigue, appetite loss, and jaundice, immediately reporting these to your physician. Regular blood tests will be recommended to monitor blood cell counts, liver, and kidney function. Prior to treatment, disclose any liver or kidney disease, and all medications, particularly those for infections, as interactions are possible. Adzine 200 Injection is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Uses of Adzine 200 Injection
Aggressive skin cancer | Hodgkin lymphoma
Major Benefits of Adzine 200 Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Adzine 200 Injection:
- Nausea
- Vomiting
- Injection site pain
- Decreased white blood cell count
- Loss of appetite
How to use Adzine 200 Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
How Adzine 200 Injection works:
Oncozine 200 Injection is an antineoplastic agent. Its mechanism of action involves disrupting the genetic structure (DNA and RNA) within cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCAUTION
Use of Adzine 200 Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Adzine 200 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Adzine 200 Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Adzine 200 Injection due to potential side effects affecting the central nervous system. Adzine 200 Injection's central nervous system effects can impact driving capabilities.
KidneyCAUTION
Adzine 200 Injection requires careful administration in individuals with impaired renal function. Dosage modification for Adzine 200 Injection may be necessary. Physician consultation is recommended.
LiverCAUTION
Exercise caution when administering Adzine 200 Injection to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Adzine 200 Injection :
Should you forget a dose of Adzine 200 Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Adzine 200 Injection
| Label | Value |
|---|---|
| Type of Compound | Triazine-based compound |
| Addictive | None. |
| Medication Category | Cancer-fighting drugs |
| Mechanism of Action | DNA-damaging drug |
3,018 People bought this recently